Check Point Software Technologies (NasdaqGS:CHKP) has partnered with AWS European Sovereign Cloud to provide cloud security ...
AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...
Phase 3 clinical trial will evaluate aglatimagene besadenovec plus valacyclovir in combination with continued pembrolizumab ...
Morning Overview on MSN
An mRNA vaccine halved the odds of aggressive melanoma returning after surgery
People treated for aggressive melanoma now have a concrete reason to watch a single experimental combination closely. In a ...
This week, the United States celebrates 250 years as a nation, a nation that was a beacon of hope for many who immigrated or ...
WRITTEN BY KATIE SMITH Whether you’re an avid hiker tackling new trails every weekend or someone who enjoys the occasional ...
Multi-cloud sounds promising on paper: more flexibility, less vendor lock-in, and the freedom to use the 'best' service from ...
Phase 3 clinical trial will evaluate aglatimagene besadenovec plus valacyclovir in combination with continued pembrolizumab versus ...
Claude Code dynamic workflows are now generally available on all paid plans, including Pro for the first time. The feature writes its own orchestration scripts and coordinates up to 1,000 parallel ...
Mark for the treatment of adult patients with locally advanced pancreatic cancer of exocrine origin, concomitant with gemcitabine and nab-paclitaxel (gem/nab-pac) ...
Cyber crime syndicates have matured into sophisticated enterprises and are no longer chaotic networks of amateurs, warn cyber ...
Morning Overview on MSN
The FDA approved a new drug for thyroid eye disease, a condition that pushes the eyes forward
Patients with thyroid eye disease, a condition that causes the eyes to bulge forward due to swelling behind the eyeball, now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results